Akouos, Inc.
Clinical trials sponsored by Akouos, Inc., explained in plain language.
Develops gene therapies for hearing loss and inner ear disorders.
Trade on eToro (ad)Not investment advice. Company information is shown for context only. Clinical trials frequently fail.
-
Gene therapy for ear tumors: Long-Term safety under review
Disease control ENROLLING_BY_INVITATIONThis study follows 100 people with vestibular schwannoma (a non-cancerous ear tumor) who previously received a gene therapy called AAVAnc80-antiVEGF. Researchers will monitor for late side effects and measure tumor size changes over time using MRI scans. The goal is to understand…
Sponsor: Akouos, Inc. • Aim: Disease control
Last updated Jul 18, 2026 00:00 UTC
-
Gene therapy for deafness: researchers track long-term safety and hearing gains
Disease control ENROLLING_BY_INVITATIONThis study follows 30 people who previously received a gene therapy (AAVAnc80-hOTOF) for hearing loss caused by otoferlin gene mutations. Researchers will monitor safety over the long term, checking for late side effects, and measure hearing improvements using brain response test…
Sponsor: Akouos, Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:04 UTC